Trademark: 79296944
Word
B BRENUS PHARMA
Status Date
Tuesday, November 23, 2021
Registration Number
6564692
Registration Date
Tuesday, November 23, 2021
Filing Date
Tuesday, August 25, 2020
Published for Opposition
Tuesday, September 7, 2021
5 Pharmaceutical products for treating pathologies that are controllable or curable by stimulated immunological reaction from a patient, namely, through infectious or oncological diseases; Veterinary products, namely, veterinary preparations for treating pathologies that are controllable or curable by stimulated immunological reaction from an animal, namely, through infectious or oncological diseases; Chemical preparations for pharmaceutical purposes, namely, for treating pathologies that are controllable or curable by stimulated immunological reaction from the patient, namely, through infectious or oncological diseases; Biological preparations for medical or therapeutic purposes, namely, preparations for the treatment of pathologies that are controllable or curable by stimulated immunological reaction from the patient, namely, through infectious or oncological diseases; Biological preparations for veterinary purposes, namely, preparations for the treatment of pathologies that are controllable or curable by stimulated immunological reaction from the patient, namely, through infectious or oncological diseases; Pharmaceutical preparations, namely, immune system aids for use in human medicine; Diagnostic preparations for medical use; Diagnostic preparations for veterinary use; Immunostimulants under the pharmaceutical monopoly; medicines in the nature of vaccinal administrations for stimulating the immune system for use in human medicine; Serums under the pharmaceutical monopoly for medical purposes, namely, pharmaceutical serums for the treatment of the immune system; Biocellular preparations for therapeutic or medical purposes, namely, pharmaceutical preparations for the treatment of the immune system
The mark consists of the black stylized wording "BRENUS" centered above the black stylized wording "PHARMA" with a short black line extending outward from each side of the wording "PHARMA", all of which is below a design of a light blue letter "B" that is surrounded by two light blue inverted triangles superimposed over one another with one appearing larger than the other. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.
A first triangle in light blue partly superimposed on a second triangle in light blue, the letter "B" in light blue located in the area of intersection of the two triangles. Below the triangles, the verbal element "BRENUS" in black, and centered below the verbal element "BRENUS", the word "PHARMA" in black, with a black line on each side of the verbal element "PHARMA"
The color(s) light blue and black are claimed as a feature of the mark.
"PHARMA"
Jul 24, 2023
New Representative At Ib Received
Jun 6, 2022
Final Decision Transaction Processed By Ib
May 12, 2022
Final Disposition Notice Sent To Ib
May 11, 2022
Final Disposition Processed
Feb 23, 2022
Final Disposition Notice Created, To Be Sent To Ib
Nov 23, 2021
Registered-Principal Register
Sep 11, 2021
Notification Processed By Ib
Sep 7, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 7, 2021
Published For Opposition
Aug 23, 2021
Notification Of Possible Opposition Sent To Ib
Aug 18, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 18, 2021
Notification Of Notice Of Publication E-Mailed
Aug 3, 2021
Approved For Pub - Principal Register
Aug 3, 2021
Examiner's Amendment Entered
Aug 3, 2021
Notification Of Examiners Amendment E-Mailed
Aug 3, 2021
Examiners Amendment E-Mailed
Aug 3, 2021
Examiners Amendment -Written
Jul 5, 2021
Teas/Email Correspondence Entered
Jul 4, 2021
Correspondence Received In Law Office
Jul 4, 2021
Teas Response To Office Action Received
Jan 30, 2021
Refusal Processed By Ib
Jan 9, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Jan 9, 2021
Refusal Processed By Mpu
Dec 24, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Dec 23, 2020
Non-Final Action Written
Dec 23, 2020
Assigned To Examiner
Nov 3, 2020
Application Filing Receipt Mailed
Oct 30, 2020
New Application Office Supplied Data Entered
Oct 29, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
